Befejeződött1. fázis
A study to investigate the safety and tolerability of intravenous QEQ278 in patients with advanced solid tumors
Key facts
- Where
- Sint-Lambrechts-Woluwe, BelgiumSee the site
- Phase
- 1. fázis
Where in Belgium
- Cliniques Universitaires Saint-LucSint-Lambrechts-Woluwe, BelgiumNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Novartis Pharma AG
- Trial code
- EU 2022-500540-38-00
- Record updated
- 2024. december 10.